31 Mar 2022
Assets3.64
Total Income5.34
Profit After Tax0.12
NET Worth1.01
Reserves and Surplus-0.49
Total Borrowing2.04
Open 13th Dec 2024 · Close 17th Dec 2024 · Listing 20th Dec 2024
The shares listed at ₹96.90, a 90.00% move from the issue price. Hamps Bio is a SME IPO with an issue size of ₹6.22 crore, proposed for listing on BSE SME. The offer opens on 13th Dec 2024 and closes on 17th Dec 2024. The issue structure includes a fresh issue of ₹5.91 crore. The current listing schedule points to 20th Dec 2024.
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 2000 | — |
| Object | Amount |
|---|---|
| Purchase of plant & machinery for FMCG division; | ₹3.59 Cr |
| Enhancing the visibility and awareness of our brand; | ₹0.50 Cr |
| General corporate purposes | ₹1.52 Cr |
| KPI | Mar 31, 2024 |
|---|---|
| ROE | 21.14% |
| ROCE | 18.31% |
| Debt / Equity | 0.31% |
| RoNW | 14.84% |
| PAT Margin | 7.73% |
| Price to Book Value | 2.96 |
| Expense | Amount |
|---|---|
| BRLM fees (including underwriting,) | ₹0.32 Cr |
| Commission / processing fee to Sponsor Bank and Bankers to the Issue. Brokerage and selling commission and bidding charges of the Registered Brokers, RTAs and CDPs | ₹0.11 Cr |
| Fees payable to Registrar to the Issue | ₹0.02 Cr |
| Fees payable to auditors and other consultants / professionals | ₹0.03 Cr |
| Listing Fees and BSE Processing Fees and other regulatory expense | ₹0.05 Cr |
| Advertising and Marketing expenses and Printing and Stationery | ₹0.02 Cr |
| Fees payable to Legal Advisors to the Issue | ₹0.01 Cr |
| Miscellaneous | ₹0.06 Cr |